Concepts (109)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Protein Engineering | 5 | 2020 | 71 | 1.780 |
Why?
|
Biocompatible Materials | 4 | 2022 | 134 | 1.240 |
Why?
|
Hydrogels | 4 | 2021 | 89 | 1.240 |
Why?
|
Anterior Cruciate Ligament Injuries | 1 | 2022 | 20 | 0.860 |
Why?
|
Cartilage, Articular | 1 | 2022 | 43 | 0.840 |
Why?
|
Cartilage Oligomeric Matrix Protein | 2 | 2018 | 3 | 0.840 |
Why?
|
Osteoarthritis | 1 | 2022 | 58 | 0.810 |
Why?
|
Chemical Warfare Agents | 1 | 2020 | 4 | 0.800 |
Why?
|
Enzymes, Immobilized | 1 | 2020 | 14 | 0.790 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 2020 | 37 | 0.780 |
Why?
|
Organophosphorus Compounds | 1 | 2020 | 31 | 0.780 |
Why?
|
Proteins | 3 | 2020 | 718 | 0.740 |
Why?
|
Pesticides | 1 | 2020 | 55 | 0.740 |
Why?
|
Protein Domains | 3 | 2019 | 126 | 0.710 |
Why?
|
Nanocomposites | 1 | 2018 | 26 | 0.640 |
Why?
|
Cellulase | 1 | 2017 | 5 | 0.620 |
Why?
|
Carboxylic Ester Hydrolases | 1 | 2017 | 11 | 0.620 |
Why?
|
Nanoconjugates | 1 | 2017 | 5 | 0.620 |
Why?
|
Peptides | 1 | 2020 | 494 | 0.600 |
Why?
|
Recombinant Fusion Proteins | 1 | 2017 | 452 | 0.540 |
Why?
|
Proto-Oncogene Proteins pp60(c-src) | 1 | 2013 | 9 | 0.500 |
Why?
|
src Homology Domains | 1 | 2013 | 21 | 0.490 |
Why?
|
Integrin beta3 | 1 | 2013 | 7 | 0.490 |
Why?
|
Monascus | 2 | 2022 | 2 | 0.440 |
Why?
|
Melanoma | 2 | 2023 | 291 | 0.370 |
Why?
|
Models, Molecular | 3 | 2020 | 1063 | 0.360 |
Why?
|
Doxorubicin | 2 | 2019 | 81 | 0.330 |
Why?
|
Polymers | 2 | 2022 | 280 | 0.320 |
Why?
|
Drug Carriers | 2 | 2019 | 156 | 0.290 |
Why?
|
Protein Conformation | 2 | 2020 | 723 | 0.290 |
Why?
|
Amino Acid Sequence | 2 | 2020 | 1488 | 0.270 |
Why?
|
Tertiary Lymphoid Structures | 1 | 2023 | 2 | 0.240 |
Why?
|
Cancer Vaccines | 1 | 2023 | 44 | 0.230 |
Why?
|
Gels | 1 | 2022 | 60 | 0.210 |
Why?
|
Rabbits | 1 | 2022 | 298 | 0.210 |
Why?
|
Chemical Phenomena | 1 | 2020 | 90 | 0.190 |
Why?
|
Hydrolysis | 1 | 2020 | 129 | 0.190 |
Why?
|
Catalysis | 1 | 2020 | 140 | 0.190 |
Why?
|
Theranostic Nanomedicine | 1 | 2019 | 6 | 0.180 |
Why?
|
Structure-Activity Relationship | 1 | 2020 | 343 | 0.180 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2019 | 25 | 0.180 |
Why?
|
Recombinant Proteins | 2 | 2019 | 634 | 0.180 |
Why?
|
Elastin | 1 | 2018 | 5 | 0.170 |
Why?
|
Elasticity | 1 | 2018 | 37 | 0.170 |
Why?
|
Spectrum Analysis | 1 | 2018 | 51 | 0.160 |
Why?
|
Anti-Inflammatory Agents | 2 | 2022 | 123 | 0.160 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2023 | 647 | 0.160 |
Why?
|
Microscopy, Confocal | 1 | 2018 | 206 | 0.160 |
Why?
|
Enzyme Stability | 1 | 2017 | 45 | 0.160 |
Why?
|
Protein Multimerization | 1 | 2018 | 154 | 0.150 |
Why?
|
Gold | 1 | 2018 | 211 | 0.140 |
Why?
|
Drug Delivery Systems | 1 | 2019 | 275 | 0.140 |
Why?
|
Polyethylene Glycols | 1 | 2017 | 161 | 0.140 |
Why?
|
Metal Nanoparticles | 1 | 2018 | 161 | 0.140 |
Why?
|
Gene Expression | 1 | 2018 | 742 | 0.130 |
Why?
|
Reishi | 1 | 2014 | 3 | 0.130 |
Why?
|
Anti-Allergic Agents | 1 | 2014 | 4 | 0.130 |
Why?
|
Drugs, Chinese Herbal | 1 | 2014 | 13 | 0.120 |
Why?
|
Hypersensitivity | 1 | 2014 | 54 | 0.120 |
Why?
|
Circular Dichroism | 1 | 2013 | 102 | 0.120 |
Why?
|
Nuclear Magnetic Resonance, Biomolecular | 1 | 2013 | 101 | 0.120 |
Why?
|
Tyrosine | 1 | 2013 | 83 | 0.120 |
Why?
|
Protein Binding | 2 | 2018 | 1479 | 0.120 |
Why?
|
Molecular Docking Simulation | 1 | 2013 | 72 | 0.120 |
Why?
|
Nanoparticles | 1 | 2019 | 444 | 0.120 |
Why?
|
Antineoplastic Agents | 1 | 2017 | 504 | 0.110 |
Why?
|
Escherichia coli | 1 | 2017 | 613 | 0.110 |
Why?
|
Autoimmune Diseases | 1 | 2014 | 181 | 0.110 |
Why?
|
Protein Structure, Tertiary | 1 | 2013 | 626 | 0.110 |
Why?
|
Bacterial Proteins | 1 | 2017 | 654 | 0.110 |
Why?
|
RNA, Small Interfering | 1 | 2017 | 794 | 0.100 |
Why?
|
Phosphorylation | 1 | 2013 | 783 | 0.100 |
Why?
|
Humans | 8 | 2023 | 49928 | 0.100 |
Why?
|
Micelles | 2 | 2019 | 70 | 0.080 |
Why?
|
Animals | 3 | 2022 | 17853 | 0.080 |
Why?
|
MCF-7 Cells | 2 | 2019 | 62 | 0.080 |
Why?
|
Hydrophobic and Hydrophilic Interactions | 2 | 2019 | 225 | 0.080 |
Why?
|
Temperature | 2 | 2019 | 276 | 0.080 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2023 | 21 | 0.060 |
Why?
|
Quercetin | 1 | 2022 | 16 | 0.060 |
Why?
|
Toll-Like Receptor 7 | 1 | 2023 | 94 | 0.060 |
Why?
|
Pigments, Biological | 1 | 2021 | 3 | 0.050 |
Why?
|
Pigmentation | 1 | 2021 | 22 | 0.050 |
Why?
|
Fermentation | 1 | 2021 | 30 | 0.050 |
Why?
|
Adjuvants, Immunologic | 1 | 2023 | 205 | 0.050 |
Why?
|
Rheology | 1 | 2021 | 55 | 0.050 |
Why?
|
Interferon-gamma | 1 | 2023 | 523 | 0.050 |
Why?
|
Plant Extracts | 1 | 2022 | 144 | 0.050 |
Why?
|
Superoxide Dismutase | 1 | 2022 | 196 | 0.050 |
Why?
|
Protein Structure, Secondary | 1 | 2021 | 235 | 0.050 |
Why?
|
Antioxidants | 1 | 2022 | 197 | 0.050 |
Why?
|
Tissue Engineering | 1 | 2021 | 130 | 0.050 |
Why?
|
Fluorine | 1 | 2019 | 9 | 0.050 |
Why?
|
Delayed-Action Preparations | 1 | 2019 | 99 | 0.040 |
Why?
|
Small Molecule Libraries | 1 | 2019 | 47 | 0.040 |
Why?
|
Mammary Neoplasms, Experimental | 1 | 2019 | 56 | 0.040 |
Why?
|
Mice, Nude | 1 | 2019 | 214 | 0.040 |
Why?
|
Cell Proliferation | 1 | 2023 | 883 | 0.040 |
Why?
|
Biomarkers | 1 | 2023 | 989 | 0.040 |
Why?
|
T-Lymphocytes | 1 | 2023 | 866 | 0.040 |
Why?
|
Amino Acid Motifs | 1 | 2018 | 150 | 0.040 |
Why?
|
Stress, Mechanical | 1 | 2018 | 133 | 0.040 |
Why?
|
Lipids | 1 | 2017 | 289 | 0.030 |
Why?
|
Patents as Topic | 1 | 2014 | 7 | 0.030 |
Why?
|
Immunomodulation | 1 | 2014 | 26 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 1 | 2019 | 1419 | 0.030 |
Why?
|
Mice | 1 | 2019 | 9208 | 0.020 |
Why?
|
Male | 1 | 2022 | 23080 | 0.010 |
Why?
|
Female | 1 | 2019 | 26376 | 0.010 |
Why?
|